Product Information
CHLORZOXAZONE 250 MG TABLET is a generic product labeled by Lifsa Drugs LLC, priced at $2.5208 per EA under NDC 72336022560. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Apr 10, 2023. Its Orange Book therapeutic-equivalence code is AA.
Strength
250 mg/1
Manufacturer
Lifsa Drugs LLCNDC
72336022560
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
CHLORZOXAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA214702FDA Approved
4/10/2023
TE Code
AA
On Market Since
3/20/2025
Pharmacological Classes
Price Statistics
The NADAC for CHLORZOXAZONE 250 MG TABLET has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5208 per EA |
|---|---|
| All-time high | $3.0642 (Jan 14, 2026) |
| All-time low | $2.5208 (Jul 22, 2026) |
| 52-week high | $3.0642 |
| 52-week low | $2.5208 |
| Median price | $2.5877 |
| Average price | $2.6593 |
| Largest weekly change | -7.6% (Jan 21, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifsa Drugs LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorzoxazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORZOXAZONE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORZOXAZONE 250 MG TABLET, manufactured by Lifsa Drugs LLC, is $2.5208 per EA (NDC 72336022560), effective Sep 30, 2026.
How has the price of CHLORZOXAZONE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORZOXAZONE 250 MG TABLET has declined 17.7%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for CHLORZOXAZONE 250 MG TABLET?
Since Dec 17, 2025, the NADAC for CHLORZOXAZONE 250 MG TABLET has ranged from a low of $2.5208 (Jul 22, 2026) to a high of $3.0642 (Jan 14, 2026), with a median of $2.5877 per EA.
Are there cheaper alternatives to CHLORZOXAZONE 250 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLORZOXAZONE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORZOXAZONE 250 MG TABLET?
CHLORZOXAZONE 250 MG TABLET (NDC 72336022560) is labeled by Lifsa Drugs LLC, and CMS classifies it as a generic product.